[Effect of the administration of Cardiostenol on experimental hepatitis in mice induced with MHV-3 virus]

V Guadagnino; G Borgia; A Chirianni; R Orlando; L Picciotto; P Tullio Cataldo; M Piazza

[Effect of the administration of Cardiostenol on experimental hepatitis in mice induced with MHV-3 virus]

Boll Soc Ital Biol Sper. 1980 Feb 29;56(4):362-8.

[Article in Italian]

Authors

V Guadagnino, G Borgia, A Chirianni, R Orlando, L Picciotto, P Tullio Cataldo, M Piazza

PMID: 6264933

Abstract

Treatment with Cardiostenol (commercial name of a pharmaceutical product containing morphine chloridrate+atropine+sparteine) does not modify the course of hepatitis in mice infected with MHV-3 virus. Similar results were previously obtained by treatment with morphine chloridrate alone.

Publication types

English Abstract

MeSH terms

Animals
Atropine / therapeutic use*
Drug Combinations / therapeutic use
Hepatitis, Viral, Animal / drug therapy*
Mice
Morphine / therapeutic use*
Murine hepatitis virus / drug effects
Sparteine / therapeutic use*

Substances

Drug Combinations
atropine, morphine drug combination
Sparteine
Morphine
Atropine